V. E. Herrin

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers

Antoun Toubaji, M. S. Achtar, Maurizio Provenzano et al. · Cancer Immunology Immunotherapy · 2008 · 120 citations · Full text

Medicine, Immunology, Oncology +17

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Osama E. Rahma, Ed Ashtar, Malgorzata Czystowska et al. · Cancer Immunology Immunotherapy · 2011 · 101 citations

Medicine, Immunology, Oncology +16

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma

Osama E. Rahma, Ed Ashtar, Ramy Ibrahim et al. · Journal of Translational Medicine · 2010 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer

Osama E. Rahma, V. E. Herrin, Rami A Ibrahim et al. · Journal of Translational Medicine · 2014 · 29 citations · Full text

Medicine, Immunology, Oncology +14

Decreasing Rates of Hospitalization for Varicella among Young Adults

V. E. Herrin, Gregory C. Gray · The Journal of Infectious Diseases · 1996 · 15 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +15